Fetal therapy is one of the most advanced areas in modern medicine, offering hope for treating life-threatening conditions before birth. Over the past two decades, this field has grown from rare, experimental interventions to evidence-based clinical procedures. In India, where birth rates remain high and fetal anomalies are a significant contributor to neonatal morbidity, the importance of fetal therapy is rapidly increasing.
At MediScan Systems, one of the leading centers for fetal medicine in India , we are committed not only to offering these therapies but also to advancing how they are delivered. This article outlines key technological trends and what expecting parents can anticipate in the coming years.
Fetal therapy refers to a range of interventions performed during pregnancy to treat fetal conditions that, if left unaddressed, could lead to poor outcomes. These include procedures such as:
These interventions are typically performed between 16 and 30 weeks of gestation and are guided by ultrasound or fetoscopy.
Fetoscopic procedures rely on inserting a tiny camera into the womb to visualize and treat abnormalities. Advances in scope diameter, image resolution, and fiber-optic lighting are making procedures safer and more precise. Research from European fetal centers such as the Fetal Medicine Foundation shows that improved optics contribute to lower complication rates during procedures like laser ablation for TTTS.
AI-assisted imaging is being developed to support real-time diagnosis and procedure planning. Machine learning algorithms are being trained to analyze fetal biometric parameters, cardiac rhythms, and vascular connections. Though not yet widespread in India, this technology is expected to support complex diagnoses in the coming years.
Globally, fetal gene therapy is in clinical trial stages. A 2022 study in Nature Medicine described early results using gene replacement therapy in utero for metabolic disorders. Similarly, fetal stem cell therapy has been used for hemoglobinopathies in select research protocols. In India, regulatory approvals are pending, but the groundwork is being laid through collaboration between pediatric geneticists, fetal medicine units, and ethics committees.
Simulation labs are being increasingly used to train fetal surgeons without putting actual pregnancies at risk. MediScan’s own Simulation Centre has trained over 200 doctors across India using high-fidelity models for procedures like cordocentesis and amniocentesis. The goal is to standardize skills and make advanced fetal care accessible in more cities
One of the challenges in India is the urban-rural divide in access to fetal care. Tele-fetal medicine—remote consultations, image sharing, and follow-up planning—is emerging as a viable solution. It allows sonologists in smaller towns to collaborate with fetal medicine experts in major centers. This trend has grown post-COVID and is expected to continue with better internet infrastructure and mobile imaging tools.
MediScan Systems is among the first institutions in India to:
With a team of fetal medicine specialists, genetic counselors, neonatologists, and anesthetists, MediScan continues to develop protocols aligned with global standards from organizations like the Society for Maternal-Fetal Medicine and the International Fetal Medicine and Surgery Society.
Fetal therapy is no longer a rare intervention but a growing standard of care for managing complex pregnancies. In India, centers like MediScan Systems are helping lead this transformation, combining clinical excellence with technological innovation. As research evolves, parents can expect even more precise, effective, and accessible fetal treatments—offering their unborn children the best possible start.
.webp)
 and How It’s Treated in the Womb.webp)
